EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Cutaneous and Subcutaneous Hyalohyphomycosis Caused by Purpureocillium Lilacinum in a Tertiary Referral Hospital in Central China

Zhi-Min Hu, Wei He, Bin Hu, Liang Zou, Liu-Qing Chen

The Journal of Dermatology · 2026

DOI: 10.1111/1346-8138.70366 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Dermatology, 2026. Verfasst von Zhi-Min Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Wuhan No. 1 Hospital, Wuhan, China. Hauptthemen laut MEDLINE: Antifungal Agents, Hyalohyphomycosis, Hypocreales, Dermatomycoses. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpureocillium lilacinum , a saprobic filamentous fungus with a global distribution, is an emerging opportunistic pathogen, but its clinical and microbiological profile in China is not well characterized. This study retrospectively analyzed three cases of Purpureocillium lilacinum hyalohyphomycosis in central China and reviewed 7 additional cases from mainland China (2010–2025). The diagnosis was made through a meticulous integration of histopathological analysis, cultivation characteristics, Matrix‐Assisted Laser Desorption Ionization‐Time of Flight Mass Spectrometry (MALDI‐TOF MS), and internal transcribed spacer (ITS) sequencing. All isolates had high minimum inhibitory concentrations (MICs) to amphotericin B, echinocandins, and fluconazole. Voriconazole and posaconazole showed the highest in vitro activity (MICs 0.12–1 mg/L and 0.25–0.5 mg/L, respectively), while itraconazole susceptibility varied (MIC 0.5–4 mg/L). Rapid and accurate identification requires confirmation via histopathology combined with MALDI‐TOF MS or molecular diagnostic methods. Successful management relies on early suspicion, susceptibility‐guided therapy with voriconazole and posaconazole, and surgical intervention when appropriate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsHyalohyphomycosisHypocrealesDermatomycosesHumansChinaTertiary Care CentersRetrospective StudiesMicrobial Sensitivity TestsFemaleMaleTriazolesSkinVoriconazoleSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationMiddle Aged

Stichwörter der Autor:innen

HyalohyphomycosisPurpureocillium lilacinumcutaneousmycosessubcutaneous

Substanzen

Antifungal AgentsTriazolesposaconazoleVoriconazole

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Wuhan No. 1 Hospital, Wuhan, China.
  • Department of Pharmacology, Wuhan No. 1 Hospital, Wuhan, China.
  • Department of Dermatology, Wuhan No. 1 Hospital, Wuhan, China.
  • Hubei Key Laboratory of Infectious and Immune Skin Diseases, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Rheumatology, Wuhan No. 1 Hospital, Wuhan, China.

Zitieren

APA

Hu, Z. M., He, W., Hu, B., Zou, L., & Chen, L. Q. (2026). Cutaneous and Subcutaneous Hyalohyphomycosis Caused by Purpureocillium Lilacinum in a Tertiary Referral Hospital in Central China. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70366

Vancouver

Hu ZM, He W, Hu B, Zou L, Chen LQ. Cutaneous and Subcutaneous Hyalohyphomycosis Caused by Purpureocillium Lilacinum in a Tertiary Referral Hospital in Central China. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70366

BibTeX
@article{Hu2026,
  author = {Hu, Zhi-Min and He, Wei and Hu, Bin and Zou, Liang and Chen, Liu-Qing},
  title = {Cutaneous and Subcutaneous Hyalohyphomycosis Caused by Purpureocillium Lilacinum in a Tertiary Referral Hospital in Central China},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70366}
}
Kostenlos starten →